SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Emisphere
EMIS 10.00-0.1%Dec 22 12:11 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (199)3/4/2003 7:31:12 PM
From: keokalani'nui  Read Replies (1) of 272
 
An ominous feeling to this. Maybe discussion of what development steps need to be taken to get the relationship they want?

CORRECTED: Emisphere Technologies, Inc. to Hold Conference Call to Discuss Oral Insulin Partnership Status
Tuesday March 4, 7:06 pm ET

TARRYTOWN, N.Y.--(BUSINESS WIRE)--March 4, 2003--Emisphere Technologies, Inc. (Nasdaq:EMIS - News) announced today that it will host a conference call and webcast at 8:00 a.m., Eastern Standard Time, on Wednesday, March 5, 2003 to discuss the status of an oral insulin partnership.
To access the live call or the seven-day archive via the internet, log on to www.emisphere.com. Please connect to the company's website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to listen to the webcast. Webcast audio will be archived on Emisphere's website. Alternatively, please call (877) 381-5116 (U.S.) or (706) 634-7378 (international) to access the call. Telephone replay is available approximately two hours after the call through 11:59 p.m., Eastern Standard Time, on March 12, 2003. To access the replay, please call (800) 642-1687 (U.S.) or (706) 645-9291 (international). The conference ID number is 8939901.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext